microRNA

Janhavi R Raut1,2, Megha Bhardwaj1, Ben Schöttker1,3

  • 1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Cancer science
|March 25, 2024
PubMed
概括

一种新的血清微RNA风险评分 (miR-score) 准确预测结直肠癌. 这一得分还显示了与乳腺癌和肺癌风险的反向关联,这表明循环miRNA生物标志物在癌症风险评估中具有更广泛的实用性.